These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6727657)

  • 1. Failure of bromocriptine to alter the qualitative characteristics of human growth hormone in acromegaly.
    Hizuka N; Hendricks CM; Roth J; Gorden P
    Metabolism; 1984 Jun; 33(6):582-4. PubMed ID: 6727657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gel filtration studies of serum growth hormone in acromegaly following bromocriptine administration.
    Benker G; Sandmann K; Tharandt L; Hackenberg K; Reinwein D
    Horm Res; 1979; 11(3):151-60. PubMed ID: 488905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of bromocriptine on serum hormones in acromegaly.
    Carlson HE; Levin SR; Braunstein GD; Spencer EM; Wilson SE; Hershman JM
    Horm Res; 1984; 19(3):142-52. PubMed ID: 6425186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative differences between immunological and receptor binding activities of hGH in pituitary adenomas from patients with acromegaly.
    Hizuka N; Takano K; Shizume K; Asakawa K; Miyakawa M
    Endocrinol Jpn; 1984 Dec; 31(6):719-24. PubMed ID: 6099801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Big" growth hormone components from human plasma: decreased reactivity demonstrated by radioreceptor assay.
    Gorden P; Lesniak MA; Hendricks CM; Roth J
    Science; 1973 Nov; 182(4114):829-31. PubMed ID: 4746491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromocriptine suppression of plasma growth hormone in acromegaly.
    Dunn PJ; Donald RA; Espiner EA
    Clin Endocrinol (Oxf); 1977 Oct; 7(4):273-81. PubMed ID: 336245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone assessment by radioreceptor and radioimmunoassay. Radioreceptor assay and radioimmunoassay comparisons.
    LaFranchi S; Hanna CE; Jelen B
    Am J Dis Child; 1984 Jan; 138(1):23-7. PubMed ID: 6537873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of acromegaly with bromocriptine.
    Steinbeck K; Turtle JR
    Med J Aust; 1978 Nov; 2(3 Suppl):35-6. PubMed ID: 745581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of molecular forms of growth hormone in bromocriptine treated acromegaly in relation to changes of somatomedin-C and clinical response.
    Nortier JW; Croughs RJ; Donker GH; Thijssen JH; Schwarz F
    Acta Endocrinol (Copenh); 1985 Feb; 108(2):145-50. PubMed ID: 4038567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homologous IM-9 lymphocyte radioreceptor and receptor modulation assays for human serum growth hormone.
    Gavin JR; Trivedi B; Daughaday WH
    J Clin Endocrinol Metab; 1982 Jul; 55(1):133-9. PubMed ID: 6281300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No effect of treatment with sodium valproate on plasma growth hormone in bromocriptine unresponsive acromegaly.
    Nortier JW; Croughs RJ; Schwarz F; Thijssen JH
    Acta Endocrinol (Copenh); 1986 Feb; 111(2):162-4. PubMed ID: 3082095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased circulating radioreceptor-active growth hormone in insulin-dependent diabetics.
    MacFarlane IA; Stafford SM; Wright AD
    Clin Endocrinol (Oxf); 1986 Nov; 25(5):607-16. PubMed ID: 3621625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bromocriptine does not alter growth hormone (GH) responsiveness to GH-releasing hormone in acromegaly.
    Cozzi R; Dallabonzana D; Oppizzi G; Verde G; Liuzzi A; Chiodini PG
    J Clin Endocrinol Metab; 1986 Mar; 62(3):601-4. PubMed ID: 3080469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term bromocriptine treatment and somatostatin in acromegaly.
    Gáspár L; László FA
    Endokrinologie; 1980 Oct; 76(2):152-62. PubMed ID: 6108852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma growth hormone suppressive effect of bromocriptine in acromegaly. Evaluation by plasma GH day profiles and plasma GH concentrations during oral glucose tolerance tests.
    Nortier JW; Croughs RJ; Thijssen JH; Schwarz F
    Clin Endocrinol (Oxf); 1984 May; 20(5):565-71. PubMed ID: 6744634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No effect of bromocriptine in acromegaly: a controlled trial.
    Lindholm J; Riishede J; Vestergaard S; Hummer L; Faber O; Hagen C
    N Engl J Med; 1981 Jun; 304(24):1450-4. PubMed ID: 7015129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bromocriptine therapy in acromegaly (author's transl)(proceedings)].
    Schaison G; Mowszowicz I
    Ann Endocrinol (Paris); 1976; 37(4):297-8. PubMed ID: 1037359
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence for higher proportion of "little" growth hormone with increased radioreceptor activity in acromegalic plasma.
    Gorden P; Lesniak MA; Eastman R; Hendricks CM; Roth J
    J Clin Endocrinol Metab; 1976 Aug; 43(2):364-73. PubMed ID: 950368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term treatment of acromegaly with bromocryptine: postprandial HGH levels and response to TRH and glucose administration.
    Benker G; Zäh W; Hackenberg K; Hamburger B; Günnewig H; Reinwein D
    Horm Metab Res; 1976 Jul; 8(4):291-5. PubMed ID: 182633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioreceptor-inactive growth hormone associated with stimulated secretion in normal subjects.
    Sneid DS; Jacobs LS; Weldon VV; Trivedi BL; Daughaday H
    J Clin Endocrinol Metab; 1975 Sep; 41(3):471-4. PubMed ID: 169286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.